MicroRNA-21 Promotes Phosphatase Gene and Protein Kinase B/phosphatidylinositol 3-kinase Expression in Colorectal Cancer

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2016 Jun 29

PMID 27350731

Citations 6

Authors

Wei-Zhong Sheng

Yu-Sheng Chen

Chuan-Tao Tu

Juan He

Bo Zhang

Wei-Dong Gao

Affiliations

Soon will be listed here.

Abstract

Aim: To explore the regulatory mechanism of the target gene of microRNA-21 (miR-21), phosphatase gene (PTEN), and its downstream proteins, protein kinase B (AKT) and phosphatidylinositol 3-kinase (PI3K), in colorectal cancer (CRC) cells.

Methods: Quantitative real-time PCR (qRT-PCR) and Western blot were used to detect the expression levels of miR-21 and PTEN in HCT116, HT29, Colo32 and SW480 CRC cell lines. Also, the expression levels of PTEN mRNA and its downstream proteins AKT and PI3K in HCT116 cells after downregulating miR-21 were investigated.

Results: Comparing the miR-21 expression in CRC cells, the expression levels of miR-21 were highest in HCT116 cells, and the expression levels of miR-21 were lowest in SW480 cells. In comparing miR-21 and PTEN expression in CRC cells, we found that the protein expression levels of miR-21 and PTEN were inversely correlated (P < 0.05); when miR-21 expression was reduced, mRNA expression levels of PTEN did not significantly change (P > 0.05), but the expression levels of its protein significantly increased (P < 0.05). In comparing the levels of PTEN protein and downstream AKT and PI3K in HCT116 cells after downregulation of miR-21 expression, the levels of AKT and PI3K protein expression significantly decreased (P < 0.05).

Conclusion: PTEN is one of the direct target genes of miR-21. Thus, phosphatase gene and its downstream AKT and PI3K expression levels can be regulated by regulating the expression levels of miR-21, which in turn regulates the development of CRC.

Citing Articles

Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy.

Wei S, Hu W, Feng J, Geng Y Cell Commun Signal. 2022; 20(1):150.

PMID: 36131281 PMC: 9490904. DOI: 10.1186/s12964-022-00960-x.

Anti-apoptotic Effect of MiR-223-3p Suppressing PIK3C2A in Cardiomyocytes from Myocardial Infarction Rat Through Regulating PI3K/Akt Signaling Pathway.

Xiaoyu L, Wei Z, Ming Z, Guowei J Cardiovasc Toxicol. 2021; 21(8):669-682.

PMID: 33999393 DOI: 10.1007/s12012-021-09658-x.

XRCC1 Gene Polymorphisms and miR-21 Expression in Patients with Colorectal Carcinoma.

Fouad H, Sabry D, Morsi H, Shehab H, Abuzaid N Eurasian J Med. 2017; 49(2):132-136.

PMID: 28638257 PMC: 5469840. DOI: 10.5152/eurasianjmed.2017.17021.

MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.

Strubberg A, Madison B Dis Model Mech. 2017; 10(3):197-214.

PMID: 28250048 PMC: 5374322. DOI: 10.1242/dmm.027441.

MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers.

Li C, Zhang K, Chen J, Chen L, Wang R, Chu X Oncotarget. 2016; 8(7):12433-12450.

PMID: 27999212 PMC: 5355356. DOI: 10.18632/oncotarget.14015.

References

Hevner R . Brain overgrowth in disorders of RTK-PI3K-AKT signaling: a mosaic of malformations. Semin Perinatol. 2014; 39(1):36-43. PMC: 4268391. DOI: 10.1053/j.semperi.2014.10.006. View

Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G . MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett. 2013; 337(2):226-36. DOI: 10.1016/j.canlet.2013.05.007. View

Song M, Salmena L, Pandolfi P . The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012; 13(5):283-96. DOI: 10.1038/nrm3330. View

Xu J, Cai J, Jin X, Yang J, Shen Q, Ding X . PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway. Oncol Rep. 2015; 34(3):1424-30. DOI: 10.3892/or.2015.4096. View

Yang S, Huang C, Li X, Yu M, He Y, Li J . miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology. 2013; 306:162-8. DOI: 10.1016/j.tox.2013.02.014. View

Mueller S, Phillips J, Onar-Thomas A, Romero E, Zheng S, Wiencke J . PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome. Neuro Oncol. 2012; 14(9):1146-52. PMC: 3424210. DOI: 10.1093/neuonc/nos140. View

Paul-Samojedny M, Pudelko A, Suchanek-Raif R, Kowalczyk M, Fila-Danilow A, Borkowska P . Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro. Tumour Biol. 2014; 36(5):3263-77. DOI: 10.1007/s13277-014-2955-0. View

Fragoso R, Barata J . Kinases, tails and more: regulation of PTEN function by phosphorylation. Methods. 2014; 77-78:75-81. DOI: 10.1016/j.ymeth.2014.10.015. View

Wang G, Shi Y, Jiang X, Leak R, Hu X, Wu Y . HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis. Proc Natl Acad Sci U S A. 2015; 112(9):2853-8. PMC: 4352818. DOI: 10.1073/pnas.1501441112. View

10.

Gayral M, Jo S, Hanoun N, Vignolle-Vidoni A, Lulka H, Delpu Y . MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer. World J Gastroenterol. 2014; 20(32):11199-209. PMC: 4145758. DOI: 10.3748/wjg.v20.i32.11199. View

11.

Xiong B, Cheng Y, Ma L, Zhang C . MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int J Oncol. 2012; 42(1):219-28. DOI: 10.3892/ijo.2012.1707. View

12.

Ye J, Cao J . MicroRNAs in colorectal cancer as markers and targets: Recent advances. World J Gastroenterol. 2014; 20(15):4288-99. PMC: 3989964. DOI: 10.3748/wjg.v20.i15.4288. View

13.

Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

14.

Parikh V, Jin R, Rabello S, Gulbahce N, White K, Hale A . MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation. 2012; 125(12):1520-32. PMC: 3353408. DOI: 10.1161/CIRCULATIONAHA.111.060269. View

15.

Sarbassov D, Guertin D, Ali S, Sabatini D . Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005; 307(5712):1098-101. DOI: 10.1126/science.1106148. View

16.

Vasen H, Watson P, Mecklin J, Lynch H . New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999; 116(6):1453-6. DOI: 10.1016/s0016-5085(99)70510-x. View

17.

Elez E, Argiles G, Tabernero J . First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405. Curr Treat Options Oncol. 2015; 16(11):52. DOI: 10.1007/s11864-015-0369-x. View

18.

Janssen H, Reesink H, Lawitz E, Zeuzem S, Rodriguez-Torres M, Patel K . Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013; 368(18):1685-94. DOI: 10.1056/NEJMoa1209026. View

19.

Yang X, Cheng Y, Li P, Tao J, Deng X, Zhang X . A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis. Tumour Biol. 2014; 36(1):383-91. DOI: 10.1007/s13277-014-2617-2. View

20.

Wei J, Feng L, Li Z, Xu G, Fan X . MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. Biomed Pharmacother. 2013; 67(5):387-92. DOI: 10.1016/j.biopha.2013.03.014. View